• 首页期刊简介编委会刊物订阅专栏专刊电子刊学术动态联系我们English
引用本文:郑造乾,骆瑾瑜,王小军,杨秀丽,袁雍,陈燕华,黄萍,丁玲.微信用药教育公众平台的构建及应用研究[J].中国现代应用药学,2014,31(12):1520-1525.
ZHENG Zaoqian,LUO Jinyu,WANG Xiaojun,YANG Xiuli,YUAN Yong,CHEN Yanhua,HUANG Ping,DING Ling.Research on Construction and Application of the Wechat Public Platform of Patient Education[J].Chin J Mod Appl Pharm(中国现代应用药学),2014,31(12):1520-1525.
【打印本页】   【HTML】   【下载PDF全文】   查看/发表评论  【EndNote】   【RefMan】   【BibTex】
←前一篇|后一篇→ 过刊浏览    高级检索
本文已被:浏览 2455次   下载 2124 本文二维码信息
码上扫一扫!
分享到: 微信 更多
微信用药教育公众平台的构建及应用研究
郑造乾1,2, 骆瑾瑜2, 王小军2, 杨秀丽2, 袁雍2, 陈燕华2, 黄萍3, 丁玲1
1.浙江大学药学院,杭州 310058;2.浙江省立同德医院药学部,杭州 310012;3.浙江省肿瘤医院药学部,杭州 310022
摘要:
目的 探讨微信公众平台用于用药教育、药物咨询的可行性,提高患者用药依从性,促进合理用药。方法 建立微信用药教育公众平台,开展公众用药教育、药物咨询服务,比较微信药物咨询与传统药物咨询的差异。结果 2013年10月1日—2014年3月31日,共724位微信用户加入微信用药教育公众平台,年龄以21~40岁为主,占71.14%。收到微信用药咨询401次,其中以咨询用药注意事项居首位,占20.70%,收到窗口药物咨询527次,其中以咨询药品有无居首位,占23.15%。在咨询内容方面微信药物咨询和窗口药物咨询存在显著差异(P<0.01)。结论 微信用药教育公众平台作为“多模态”新兴媒介适用于用药教育和药物咨询,可在医院中推广应用。
关键词:  微信  微信公众平台  用药教育  药物咨询  用药指导
DOI:
分类号:
基金项目:浙江省药学会医院药学专项科研资助项目(2013ZYY03);浙江省医药卫生科技计划项目(2013KYB063,2012KYA041)
Research on Construction and Application of the Wechat Public Platform of Patient Education
ZHENG Zaoqian1,2, LUO Jinyu2, WANG Xiaojun2, YANG Xiuli2, YUAN Yong2, CHEN Yanhua2, HUANG Ping3, DING Ling1
1.College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China;2.Department of Pharmacy, Tongde Hospital of Zhejiang Province, Hangzhou 310012, China;3.Department of Pharmacy, Zhejiang Cancer Hospital, Hangzhou 310022, China
Abstract:
OBJECTIVE To investigate the feasibility of the WeChat Public Platform for patient education and drug consultation, so as to improve the patients medication compliance, promote rational drug application. METHODS Established the WeChat Public Platform of patient education and carried out the service of public patient education and drug consultation. Compared the difference between WeChat drug consultation and on site drug consultation. RESULTS From October 1, 2013 to March 31, 2014, a total of 724 WeChat users joined the WeChat Public Platform of patient education and the aged from 21 to 40 accounting for 71.14%. Received the WeChat drug consultation 401 times and with consulting medical attention in the first place, accounted for 20.70%. Received the on site drug consultation 527 times and with consulting drugs have or not in the first place, accounting for 23.15%. WeChat drug consultation and on site drugs consultation significant differences on consulting content(P<0.01). CONCLUSION WeChat Public Platform of patient education as a multimodal emerging media is suitable for patient education and drug consultation. It can be widely used in hospital.
Key words:  WeChat  WeChat Public Platform  patient education  consultation on medicine  directions on using the medicine
扫一扫关注本刊微信